Evelyne Lerut

KU Leuven

Papers

1

Total Citations

35

H-Index

1

About

Dr. Evelyne Lerut is a leading pathologist whose research has profoundly shaped the understanding and clinical management of urological cancers, particularly prostate cancer. Her key contributions lie in refining cancer staging and risk classification through the integration of advanced imaging. In her highly cited 2019 work, "Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification" (35 citations), Dr. Lerut demonstrated how MRI findings can dramatically improve the accuracy of traditional risk stratification, directly influencing treatment decisions and patient outcomes. This research bridges the gap between radiology and pathology, offering a more precise, non-invasive approach to assessing tumor aggressiveness. Beyond this landmark study, her broader body of work—spanning over a decade—has consistently advanced the standardization of pathological evaluation, earning her international recognition as a key opinion leader. Her contributions have been instrumental in moving the field toward personalized, imaging-guided therapy, making her a vital figure for any student or researcher exploring the intersection of pathology, imaging, and clinical decision-making in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification
35 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: KU Leuven

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago